{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:04:21Z","timestamp":1785499461337,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113719","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:47:48Z","timestamp":1785498468000},"source":"Crossref","is-referenced-by-count":0,"title":["The Intersection of Autoimmunity and Sleep: Anti-IgLON5 as the Key Player in a Case Series"],"prefix":"10.7759","author":[{"given":"Benjamin  Earnest","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Vijaykrishnan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VigneshKumar","family":"Kathiresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Sivadasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamugesh","family":"Thangakunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devasahayam Jesudas","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjith","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John AJ","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater L","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, et al.. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014, 13:575-86. 10.1016\/S1474-4422(14)70051-1","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns MW","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991, 14:540-5. 10.1093\/sleep\/14.6.540","journal-title":"Sleep"},{"key":"ref3","unstructured":"The AASM manual for the scoring of sleep and associated events. (2025). Accessed. August 26, 2025: https:\/\/aasm.org\/clinical-resources\/scoring-manual\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi E","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F, et al.. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016, 132:531-43. 10.1007\/s00401-016-1591-8","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200353","article-title":"Anti-IgLON5 disease 10 years later: what we know and what we do not know","volume":"12","author":"Graus F","year":"2025","unstructured":"Graus F, Sabater L, Gaig C, Gelpi E, Iranzo A, Dalmau JO, Santamaria J. Anti-IgLON5 disease 10 years later: what we know and what we do not know. Neurol Neuroimmunol Neuroinflamm. 2025, 12:e200353. 10.1212\/NXI.0000000000200353","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig C","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, et al.. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017, 88:1736-43. 10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat JA","year":"2017","unstructured":"Honorat JA, Komorowski L, Josephs KA, et al.. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017, 4:e385. 10.1212\/NXI.0000000000000385","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01056","article-title":"Anti-IgLON5 disease: a case with 11-year clinical course and review of the literature","volume":"10","author":"Nissen MS","year":"2019","unstructured":"Nissen MS, Blaabjerg M. Anti-IgLON5 disease: a case with 11-year clinical course and review of the literature. Front Neurol. 2019, 10:1056. 10.3389\/fneur.2019.01056","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11016","article-title":"Late-onset narcolepsy type 1 comorbid with anti-IgLON5 disease in an older male patient","volume":"20","author":"Wang X","year":"2024","unstructured":"Wang X, Yuan N, Zhang X, Liu Y. Late-onset narcolepsy type 1 comorbid with anti-IgLON5 disease in an older male patient. J Clin Sleep Med. 2024, 20:829-32. 10.5664\/jcsm.11016","journal-title":"J Clin Sleep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13207","article-title":"Response to immunotherapy in anti-IgLON5 disease: a systematic review","volume":"141","author":"Cabezudo-Garc\u00eda P","year":"2020","unstructured":"Cabezudo-Garc\u00eda P, Mena-V\u00e1zquez N, Estivill Torr\u00fas G, Serrano-Castro P. Response to immunotherapy in anti-IgLON5 disease: a systematic review. Acta Neurol Scand. 2020, 141:263-70. 10.1111\/ane.13207","journal-title":"Acta Neurol Scand"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000962","article-title":"Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome","volume":"8","author":"Werner J","year":"2021","unstructured":"Werner J, Jelcic I, Schwarz EI, et al.. Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome. Neurol Neuroimmunol Neuroinflamm. 2021, 8:962. 10.1212\/NXI.0000000000000962","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-201105","article-title":"Hypothalamic-bulbar MRI hyperintensity in anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature","volume":"79","author":"Tagliapietra M","year":"2021","unstructured":"Tagliapietra M, Frasson E, Cardellini D, et al.. Hypothalamic-bulbar MRI hyperintensity in anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature. J Alzheimers Dis. 2021, 79:683-91. 10.3233\/JAD-201105","journal-title":"J Alzheimers Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60445-7","article-title":"IgLON5 autoimmunity and abnormal behaviours during sleep","volume":"385","author":"H\u00f6gl B","year":"2015","unstructured":"H\u00f6gl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015, 385:1590. 10.1016\/S0140-6736(15)60445-7","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter T","year":"2023","unstructured":"Gr\u00fcter T, M\u00f6llers FE, Tietz A, et al.. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain. 2023, 146:600-11. 10.1093\/brain\/awac090","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170189","article-title":"Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy","volume":"59","author":"Cagnin A","year":"2017","unstructured":"Cagnin A, Mariotto S, Fiorini M, et al.. Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy. J Alzheimers Dis. 2017, 59:13-20. 10.3233\/JAD-170189","journal-title":"J Alzheimers Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467154-the-intersection-of-autoimmunity-and-sleep-anti-iglon5-as-the-key-player-in-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:47:49Z","timestamp":1785498469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467154-the-intersection-of-autoimmunity-and-sleep-anti-iglon5-as-the-key-player-in-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.113719","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}